128 related articles for article (PubMed ID: 35595078)
41. Two-year outcomes of statin therapy in patients with acute myocardial infarction with or without dyslipidemia after percutaneous coronary intervention in the era of new-generation drug-eluting stents within Korean population: Data from the Korea Acute Myocardial Infarction Registry.
Kim YH; Her AY; Jeong MH; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2019 Jun; 93(7):1264-1275. PubMed ID: 30474346
[TBL] [Abstract][Full Text] [Related]
42. Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial.
Hofma SH; Brouwer J; Velders MA; van't Hof AW; Smits PC; Queré M; de Vries CJ; van Boven AJ
J Am Coll Cardiol; 2012 Jul; 60(5):381-7. PubMed ID: 22835668
[TBL] [Abstract][Full Text] [Related]
43. Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
Di Lorenzo E; Sauro R; Varricchio A; Capasso M; Lanzillo T; Manganelli F; Carbone G; Lanni F; Pagliuca MR; Stanco G; Rosato G; Suryapranata H; De Luca G
JACC Cardiovasc Interv; 2014 Aug; 7(8):849-56. PubMed ID: 25147029
[TBL] [Abstract][Full Text] [Related]
44. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
[TBL] [Abstract][Full Text] [Related]
45. Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
Baber U; Stefanini GG; Giustino G; Stone GW; Leon MB; Sartori S; Aquino M; Steg PG; Windecker S; Wijns W; Serruys PW; Valgimigli M; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari DE; von Birgelen C; Dangas GD; Galatius S; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
Circ Cardiovasc Interv; 2019 Jul; 12(7):e007734. PubMed ID: 31288561
[TBL] [Abstract][Full Text] [Related]
46. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
47. Comparison of two biodegradable-polymer-based sirolimus-eluting stents with varying elution and absorption kinetics in patients with acute myocardial infarction: A subgroup analysis of the PANDA III trial.
Guan C; Xu B; Qiao S; Qin L; Li Y; Li Z; Guo Y; Sun Z; Song L; Gao R;
Catheter Cardiovasc Interv; 2017 Mar; 89(S1):520-527. PubMed ID: 28109057
[TBL] [Abstract][Full Text] [Related]
48. Clinical impact of second-generation everolimus-eluting stents compared with first-generation drug-eluting stents in diabetic patients undergoing multivessel percutaneous coronary intervention.
Pendyala L; Loh J; Kitabata H; Minha S; Chen F; Torguson R; Suddath W; Satler L; Pichard A; Waksman R
J Invasive Cardiol; 2015 Jun; 27(6):263-8. PubMed ID: 26028652
[TBL] [Abstract][Full Text] [Related]
49. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
[TBL] [Abstract][Full Text] [Related]
50. Comparison of clinical outcomes between angiotensin-converting-enzyme inhibitors and ARBs in patients with acute myocardial infarction with dyslipidemia after a successful stent implantation.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Anatol J Cardiol; 2020 Jan; 23(2):86-98. PubMed ID: 32011324
[TBL] [Abstract][Full Text] [Related]
51. Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome.
Ma YL; Tang XF; Yao Y; Xu N; Song Y; Jiang P; Xu JJ; Wang HH; Jiang L; Liu R; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
Chin Med J (Engl); 2018 Jun; 131(12):1397-1405. PubMed ID: 29893356
[TBL] [Abstract][Full Text] [Related]
52. ST-elevation versus non-ST-elevation myocardial infarction after combined use of statin with renin-angiotensin system inhibitor: Data from the Korea Acute Myocardial Infarction Registry.
Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Cardiol J; 2022; 29(4):647-659. PubMed ID: 33634844
[TBL] [Abstract][Full Text] [Related]
53. Everolimus-eluting stents versus sirolimus- or paclitaxel-eluting stents: two-year results from the Guthrie Health Off-Label Stent (GHOST) registry.
Harjai KJ; Kondareddy S; Pinkosky B; Harjai N; Orshaw P; Boura J
J Interv Cardiol; 2013 Apr; 26(2):153-62. PubMed ID: 23363439
[TBL] [Abstract][Full Text] [Related]
54. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry.
Abe D; Sato A; Hoshi T; Maruta S; Misaki M; Kakefuda Y; Watabe H; Hiraya D; Sakai S; Kawabe M; Takeyasu N; Aonuma K
J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689
[TBL] [Abstract][Full Text] [Related]
55. Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery disease: A systematic review and meta-analysis.
Bundhun PK; Soogund MZS; Pursun M; Chen MH
Medicine (Baltimore); 2016 Jul; 95(27):e4130. PubMed ID: 27399125
[TBL] [Abstract][Full Text] [Related]
56. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction.
Zhang Q; Shen J; Zhang RY; Qiu JP; Lu JD; Zhang Y; Chen YH; Zhang JF; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
Chin Med J (Engl); 2007 Nov; 120(21):1862-7. PubMed ID: 18067756
[TBL] [Abstract][Full Text] [Related]
57. Long-Term Clinical Outcomes of Biodegradable-Polymer Drug-Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents for ST-Segment Elevation Myocardial Infarction.
Sim HW; Thong EH; Djohan AH; Chen JZ; Ser JS; Loh PH; Lee CH; Chan MY; Low AF; Tay EL; Chan KH; Tan HC; Loh JP
Cardiovasc Revasc Med; 2022 Feb; 35():98-103. PubMed ID: 33893053
[TBL] [Abstract][Full Text] [Related]
58. Comparison of clinical outcomes between first-generation and second-generation drug-eluting stents in type 2 diabetic patients.
Jeong HS; Cho JY; Kim EJ; Yu CW; Ahn CM; Park JH; Hong SJ; Lim DS
Coron Artery Dis; 2013 Dec; 24(8):676-83. PubMed ID: 23994881
[TBL] [Abstract][Full Text] [Related]
59. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial.
Tuomainen PO; Ylitalo A; Niemelä M; Kervinen K; Pietilä M; Sia J; Nyman K; Nammas W; Airaksinen KE; Karjalainen PP
Int J Cardiol; 2013 Sep; 168(2):1214-9. PubMed ID: 23218575
[TBL] [Abstract][Full Text] [Related]
60. Comparison of 2-year clinical outcomes between diabetic versus nondiabetic patients with acute myocardial infarction after 1-month stabilization: Analysis of the prospective registry of DIAMOND (DIabetic acute myocardial infarctiON Disease) in Korea: an observational registry study.
Hur SH; Won KB; Kim IC; Bae JH; Choi DJ; Ahn YK; Park JS; Kim HS; Choi RK; Choi D; Kim JH; Han KR; Park HS; Choi SY; Yoon JH; Gwon HC; Rha SW; Jang W; Bae JW; Hwang KK; Lim DS; Jung KT; Oh SK; Lee JH; Shin ES; Kim KS;
Medicine (Baltimore); 2016 Jun; 95(25):e3882. PubMed ID: 27336875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]